У нас вы можете посмотреть бесплатно Afirma Genomic Test | 2023 American Thyroid Association Poster Presentation | NIS или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
Working together with the cancer community, Veracyte’s mission is to advance thyroid cancer care with exceptional genomic testing for personalized treatment planning. In this video, Dr. Prasana Santhanam, MBBS, Johns Hopkins University School of Medicine, presents key data from his 2023 ATA poster, “Sodium Iodide Symporter (NIS) Expression in Cytologically Indeterminate and Malignant Thyroid Nodules”, highlighting the potential for NIS expression to serve as a predictive marker for treatment response and personalized treatments for differentiated thyroid cancer. Discover how Dr. Santhanam used Veracyte’s Afirma Genomic Sequencing Classifier to examine the pre- operative mRNA expression of NIS in over 47,000 fine-needle aspiration samples from thyroid nodules, revealing nodules classified as indeterminate or suspicious for malignancy showed lower NIS expression than benign nodules and how NIS was differentially expressed relative to genomic variants and fusions found in the nodule by the Afirma Xpression Atlas variant and fusion panel. KEY TOPICS 0:00 - INTRODUCTION 0:55 - PURPOSE & METHOD 1:50 - RESULTS 2:55 - CONCLUSION RESOURCES To stay up to date on the latest in molecular testing for personalized cancer care: Learn more about the Afirma molecular test genomic sequencing classifier for thyroid cancer, https://www.veracyte.com/thyroid-cancer/ Explore clinical evidence and publications, https://www.veracyte.com/publications/ For the latest news and information about Veracyte, https://www.veracyte.com/in-the-news/ STAY CONNECTED We believe exceptional cancer care begins with exceptional diagnostics. Visit www.veracyte.com to learn more about our genomic tests. Subscribe to Veracyte’s YouTube channel for more information on how we are empowering clinicians and patients with high-value insights, / veracyte Join Veracyte and Afirma on LinkedIn, / veracyte Join Veracyte and Afirma on X, https://x.com/Veracyte #thyroidhealth #thyroidcancer #thyroidnodules #earlydetectionsaveslives #genomictesting #moleculartesting #endo #endocrine #endocrinology #AfirmaGenomicSequencingClassifier #Veracyte